Publication | Closed Access

Pharmacokinetic and pharmacodynamic study of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study

Metabolic SyndromeDiabetes ManagementMedicineDiabetesType 2PharmacotherapyDiabetes MellitusPharmacologyJapanese Patients